A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: A European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score

Heart

Volumn 100, Issue 2, 2014, Pages 115-125

  Salah, Khibar ^a   Kok, Wouter E ^a   Eurlings, Luc W ^b   Bettencourt, Paulo ^c   Pimenta, Joana M ^c   Metra, Marco ^d   Bayes Genis, Antoni ^e   Verdiani, Valerio ^f   Bettari, Luca ^d   Lazzarini, Valentina ^d   Damman, Peter ^a   Tijssen, Jan G ^a   Pinto, Yigal M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c University of Porto   (Portugal)

^d Radiological Sciences and Public Health ^*  (Italy)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; UREA;

ACUTE HEART FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL; VALIDATION PROCESS; VERY ELDERLY;

EID: 84891836113     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303632     Document Type: Article

References (43)

1. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18: 208-25. (Pubitemid 27107582)
2. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A-13A. (Pubitemid 23285789)
3. Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with HF: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999;137: 352-60. (Pubitemid 29070149)
4. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006;27: 330-7. (Pubitemid 43100029)
5. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347: 161-7. (Pubitemid 34764819)
6. Hartmann F, Packer M, Coats AJ, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004;110: 1780-6. (Pubitemid 39302655)
7. Bayés-Genís A, Lopez L, Zapico E, et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail 2005;11:S3-8.
8. Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110: 2168-74. (Pubitemid 39372496)
9. Metra M, Nordari S, Parrinello G, et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 2007;9: 776-86. (Pubitemid 47212835)
10. O'Brien R, Squire IB, Demme B, et al. Predischarge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail 2003;5: 499-506. (Pubitemid 37021644)
11. Verdiani V, Ognibene A, Rutili MS, et al. NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients. J Cardiovasc Med 2008;9: 694-9.
12. Bhardwaj A, Januzzi JL Jr. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm. Crit Pathw Cardiol 2009;8: 146-50.
13. O'Connor CM, Hasselblad V, Mehta RH, et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol 2010;55: 872-8.
14. Felker GM, Leimberger JD, Califf RM, et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail 2004;10: 460-6.
15. Fonarow GC, Adams KF jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293: 572-80. (Pubitemid 40171239)
16. Lee D, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of clinical model. JAMA 2003;290: 2581-7. (Pubitemid 37443288)
17. Rosenthal GE, Baker DW, Norris DG, et al. Relationships between in-hospital and 30-day standardized hospital mortality: implications for profiling hospitals. Health Serv Res 2000;34: 1449-68. (Pubitemid 30133837)
18. Selker HP, Griffith JL, D'Agostino RB. A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care 1994;32: 1040-52.
19. Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002;25: 76-97. (Pubitemid 34157785)
20. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341: 418-22. (Pubitemid 23048157)
21. Simmonds MC, Higgins JP, Stewart LA, et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005;2: 209-17. (Pubitemid 40910470)
22. Kubler P, Jankowska EA, Majda J, et al. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Int J Cardiol 2008;129: 373-8.
23. Pimenta JM, Almeida R, Araújo JP, et al. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study. J Card Fail 2007;13: 275-80. (Pubitemid 46756339)
24. Eurlings LW, van Pol PE, Kok WE, et al. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol 2010;56: 2090-100.
25. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14: 803-69.
26. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10: 933-89.
27. Bettencourt P, Azevedo A, Fonseca L, et al. Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. Int J Cardiol 2007;117: 75-9. (Pubitemid 46399972)
28. Cohen-Solal A, Logeart D, Huang B, et al. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol 2009;53: 2343-8.
29. Ferreira S, Almeida R, Guerrero H, et al. Prognosis of decompensated heart failure: role of NT-proBNP. Rev Port Cardiol 2007;26: 535-45. (Pubitemid 47067555)
30. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28: 980-8. (Pubitemid 47343897)
31. Harjola VP, Fallath F, Nieminen MS, et al. Characteristics,outcomes,and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12: 239-48.
32. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43: 635-41. (Pubitemid 38229537)
33. Pencina MJ, D'Agostino RB Sr, D' Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27: 157-72. (Pubitemid 351193639)
34. Richards M, Troughton RW. NT-proBNP in heart failure: therapy decisionsand monitoring. Eur J Heart Fail 2004;6:351-4. (Pubitemid 38253056)
35. Eur J Heart Fail 2004;6: 351-354.
36. Siirilä-Waris K, Lassus J, Melin J, et al. Characteristics,outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 2006;27: 3011-17. (Pubitemid 44950446)
37. Klein L, O'Conner CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005;111: 2454-60. (Pubitemid 40696133)
38. Damman K, Jaarsma T, Voors AA, et al. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009;11: 847-54.
39. Ilva T, Lassus J, Siirila-Waris K, et al. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008;10: 772-9.
40. Peacock WF, De MT, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358: 2117-26.
41. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26: 1565-74.
42. Postmus D, van Veldhuisen DJ, Jaarsma T, et al. The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure. Eur J Heart Fail 2012;14: 168-75.
43. Kociol RD, Horton JR, Fonarow GC, et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail 2011;4: 628-36.